Rein Therapeutics Statistics
NASDAQ: RNTXHealth CareBiotechnology: Pharmaceutical PreparationsUSD
0.78-0.0087 (-1.10%)
Market open · Delayed 15 min · as of Oct 8, 9:30 AM ET
Rein Therapeutics by the numbers
Rein Therapeutics has a market capitalization of $67.3 million based on 86.27M shares outstanding. With trailing EPS of $-1.68, Rein Therapeutics is unprofitable on a 12-month basis, so earnings-based valuation ratios do not apply. The stock trades 1.0% below its 50-day average and 28.2% below its 200-day average.
Average daily trading volume is 428.25K shares, or about $334,032 in dollar volume.
Summary generated from market data by MetaCap's automated system. Methodology
RNTX valuation vs. peer median
| Metric | RNTX | Peer median | Difference |
|---|---|---|---|
| Market cap | $67.29M | $70.33M | -4% |
| Avg. volume | 428.25K | 516.87K | -17% |
Peer median across 8 companies: FBIO, XBIT, SPRO, TENX, MAIA, HYFT, HRTX, CING.
Valuation
- Market cap
- $67.29M
- EPS (TTM)
- $-1.68
- Shares outstanding
- 86.27M
Price and trading
- Previous close
- 0.7887
- Open
- 0.784
- Day range
- 0.78 – 0.784
- 52-week range
- 0.694 – 2.18
- 52-week change
- -45.23%
- 50-day moving average
- 0.7876
- Beta
- —
- Volume
- 3.48K
- Average volume
- 428.25K
Dividends and events
- Annual dividend
- None
- Next earnings date
- Aug 12, 2025
Additional statistics
- Market Cap
- 67.29M
- Eps
- -1.68
- Dividend Yield
- 0.00%
- Dividend Rate
- 0.00
- Week52 High
- 2.18
- Week52 Low
- 0.69
- Avg Volume
- 428.25K
- Shares Outstanding
- 86.27M
- Ma50
- 0.79
- Ma200
- 1.09
- Earnings Date
- Aug 12, 2025
- Pct From52w High
- -64.22%
- Pct From52w Low
- 12.39%